Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for six debilitating neurodevelopmental disorders that emerge in early childhood and are characterised by impaired connections and signalling between brain cells.
Company Details
- Employees
- 30
- Address
- Camberwell, Vic 3124, Au
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.neurenpharma.com
- HQ
- Camberwell, VIC
Neuren Pharmaceuticals Limited Questions
Neuren Pharmaceuticals Limited's website is http://www.neurenpharma.com
Neuren Pharmaceuticals Limited's LinkedIn profile is https://au.linkedin.com/company/neuren-pharmaceuticals-limited
Neuren Pharmaceuticals Limited has
30 employees.
View email and phone details for 30
employees at Neuren Pharmaceuticals Limited.
Neuren Pharmaceuticals Limited's industry is
Biotechnology Research
Neuren Pharmaceuticals Limited's top competitors are
Telix Pharmaceuticals Limited,
Aft Pharmaceuticals,
Vitura Health (Asx:vit),
Clarity Pharmaceuticals,
Recce Pharmaceuticals Ltd,
Incannex Healthcare Inc,
Acadia Pharmaceuticals Inc.,
Clinuvel Pharmaceuticals Ltd,
Mayne Pharma,
Mayne Pharma Australia.
Neuren Pharmaceuticals Limited's categories are Biotechnology Research
